InsiderTrades

Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/

Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-30 · accession 0001657070-23-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-03 2023-06-30 KEQU HULL THOMAS DAVID III Pres, CEO, Dir F - Tax $15.90 -2,960 41.2K -7% -$47.1K
D 2023-07-03 2023-06-30 KEQU HULL THOMAS DAVID III Pres, CEO, Dir M - OptEx $0.00 +10.5K 44.2K +31% $0
DM 2023-07-03 2023-06-30 KEQU HULL THOMAS DAVID III Pres, CEO, Dir M - OptEx $0.00 -10.5K 10.7K -49% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-30 F D 2,960 $15.90 41,200 D — —
2 Common Common Stock 2023-06-30 M A 10,453 $0.00 44,160 D — — (F1) Restricted stock units convert to common stock on a one-for-one basis.
3 Derivative Restricted Stock Units FY22 2023-06-30 M D 5,096 $0.00 5,097 D — · — to — 5,096 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) On June 23, 2021, the reporting person was granted restricted stock units that vest as follows: (a) 100% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 30, 2022, subject to the reporting person's continued employment with the Company.
4 Derivative Restricted Stock Units FY23 2023-06-30 M D 5,357 $0.00 10,714 D — · — to — 5,357 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F3) On June 29, 2022, the reporting person was granted restricted stock units that vest as follows: (a) 100% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 30, 2023, subject to the reporting person's continued employment with the Company.